🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11792+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11792 recruiting trials

RecruitingNCT06796335

Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour

🏥 Rigshospitalet, Denmark📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06593951

Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)

🏥 Boston Children's Hospital📍 1 site📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT05961059

InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia

🏥 Leiden University Medical Center📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06405438

Comparison of the Efficacy of Peloid Therapy and Paraffin Treatment in Carpal Tunnel Syndrome

👨‍⚕️ Büşra Şirin Ahısha, MD, Beylikdüzü State Hospital📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06609668

Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)

🏥 Centre Hospitalier Universitaire Dijon📍 1 site📅 Started Oct 2024View details ↗
Phase 1, PHASE2RecruitingNCT06511050

Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

👨‍⚕️ David Putrino, PhD, PT, Icahn School of Medicine at Mount Sinai📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT05996185

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

👨‍⚕️ Tarsheen Sethi, MD, Yale University📍 2 sites📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06470048

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 127 sites📅 Started Oct 2024View details ↗
NARecruitingNCT06975332

Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression

👨‍⚕️ Przemysław Kunert, Professor, Department of Neurosurgery, Medical University of Warsaw, Poland📍 2 sites📅 Started Oct 2024View details ↗
Phase 1, PHASE2RecruitingNCT06675422

JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)

👨‍⚕️ Sanbin Wang, Doctor, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06596187

Differential Assessment of Hypertonia

🏥 Chang Gung University📍 1 site📅 Started Oct 2024View details ↗
Phase 1, PHASE2RecruitingNCT06303752

Tissue Therapy of Transsphincteric Anal Fistula

👨‍⚕️ Karam M Sørensen, OUH📍 1 site📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT06525636

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

👨‍⚕️ Kyowa Kirin, Kyowa Kirin, Inc.📍 9 sites📅 Started Oct 2024View details ↗
RecruitingNCT06279442

Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort

👨‍⚕️ Milena Shizue Tariki, Latin American Cooperative Oncology Group📍 10 sites📅 Started Oct 2024View details ↗
NARecruitingNCT06222203

Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

👨‍⚕️ Brigitte C Widemann, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT06632236

5G-EMERALD: Amivantamab in Malignant Brain Tumours

👨‍⚕️ Juanita Lopez, MD, PhD, National Health Service, UK📍 2 sites📅 Started Oct 2024View details ↗
NARecruitingNCT07277361

Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment

👨‍⚕️ Wladimir MAUHIN, Doctor, Groupe Hospitalier Diaconesses Croix Saint-Simon📍 1 site📅 Started Oct 2024View details ↗
Phase 3Enrolling by InvitationNCT06540144

An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis

👨‍⚕️ UCB Cares, 001 844 599 2273📍 10 sites📅 Started Oct 2024View details ↗
RecruitingNCT06607302

Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study

🏥 iOMEDICO AG📍 7 sites📅 Started Oct 2024View details ↗
RecruitingNCT06647641

The CurePSP Genetics Program

🏥 Massachusetts General Hospital📍 1 site📅 Started Oct 2024View details ↗
← PreviousPage 225 of 590Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →